Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects

Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects

Abstract Background The gut microbiota plays a pivotal role in ulcerative colitis (UC) development. This study explores the impact of latent tuberculosis infection (LTBI) on the gut microbiota in UC and assesses changes during vedolizumab treatment, investigating prophylactic anti-tuberculosis thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Yibing Hu, Zhenping Wu, Xiaoyun Yang, Jin Ding, Qunying Wang, Hao Fang, Lujian Zhu, Minli Hu
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Microbiology
Subjects:
Ulcerative colitis
Vedolizumab
Latent tuberculosis infection
Gut microbiota
Prophylactic treatment
Online Access:https://doi.org/10.1186/s12866-024-03705-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12866-024-03705-7

Similar Items